Verition Fund Management
EW icon

Verition Fund Management’s Edwards Lifesciences EW Stock Holding History

Verition Fund Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,200
Closed -$955K – 2683
2025
Q4 		$955K Sell
11,200
-39,500
-78% -$3.24M ﹤0.01% 2187
2025
Q3 		$3.94M Buy
50,700
+2,900
+6% +$227K 0.02% 1392
2025
Q2 		$3.74M Buy
47,800
+3,100
+7% +$231K 0.02% 1410
2025
Q1 		$3.24M Buy
44,700
+29,400
+192% +$2.1M 0.02% 1213
2024
Q4 		$1.13M Sell
15,300
-5,300
-26% -$371K ﹤0.01% 1965
2024
Q3 		$1.36M Hold
20,600
– – 0.01% 1669
2024
Q2 		$1.9M Buy
20,600
+12,800
+164% +$1.13M 0.01% 1300
2024
Q1 		$745K Buy
+7,800
New +$655K 0.01% 1783
2023
Q3 		– Sell
-2,400
Closed -$226K – 2442
2023
Q2 		$226K Buy
+2,400
New +$209K ﹤0.01% 1753
2023
Q1 		– Sell
-4,700
Closed -$351K – 2259
2022
Q4 		$351K Hold
4,700
– – 0.01% 1414
2022
Q3 		$388K Buy
+4,700
New +$452K ﹤0.01% 2056
2022
Q2 		– Sell
-8,700
Closed -$1.02M – 2562
2022
Q1 		$1.02M Buy
8,700
+6,700
+335% +$752K 0.01% 1439
2021
Q4 		$259K Buy
+2,000
New +$233K ﹤0.01% 2076

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Verition Fund Management's EW Position: Q2 2026 in Review

Verition Fund Management increased its Edwards Lifesciences (EW) stake by 3,223% in Q2 2026, buying an estimated $16.3M and bringing the position to 200,695 shares worth $18.2M. The position accounts for 0.09% of the portfolio, ranked #226.

Verition Fund Management first reported a position in EW in Q3 2013 and has held it in 34 quarters since. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Verition Fund Management held 200,695 shares of Edwards Lifesciences worth $18.2M as of Q2 2026.
  • Verition Fund Management bought 194,655 Edwards Lifesciences shares in Q2 2026, an estimated $16.3M.
  • Edwards Lifesciences made up 0.09% of Verition Fund Management's portfolio in Q2 2026, its #226 holding.
  • Verition Fund Management first reported a position in Edwards Lifesciences in Q3 2013 and has held it in 34 quarters since.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.